Search Results - "BADGWELL, Donna"
-
1
Development of a Multimarker Assay for Early Detection of Ovarian Cancer
Published in Journal of clinical oncology (01-05-2010)“…Early detection of ovarian cancer has great promise to improve clinical outcome. Ninety-six serum biomarkers were analyzed in sera from healthy women and from…”
Get full text
Journal Article -
2
Early detection of ovarian cancer
Published in Disease markers (2007)“…Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological cancers. Less than 30% of women with advanced stage disease survive…”
Get full text
Journal Article -
3
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer
Published in International journal of gynecological cancer (01-07-2016)“…Longitudinal multimarker combinations have the potential to improve sensitivity while maintaining the high specificity required for the early detection of…”
Get more information
Journal Article -
4
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer
Published in Gynecologic oncology (01-09-2011)“…Abstract Objective The low prevalence of ovarian cancer demands both high sensitivity (> 75%) and specificity (99.6%) to achieve a positive predictive value of…”
Get full text
Journal Article -
5
IL-6 signaling via the STAT3/SOCS3 pathway: Functional Analysis of the Conserved STAT3 N-domain
Published in Molecular and cellular biochemistry (01-08-2006)“…The conserved N-domain of the STAT proteins has been implicated in several activities crucial to cytokine signaling including receptor recruitment and STAT…”
Get full text
Journal Article -
6
Ethanol and aloe emodin alter the p53 mutational spectrum in ultraviolet radiation-induced murine skin tumors
Published in Molecular carcinogenesis (01-03-2004)“…Mutations in the p53 tumor‐suppressor gene contribute to the development of skin cancer, and the spectrum of mutations in this gene correlates with specific…”
Get full text
Journal Article -
7
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
Published in Gynecologic oncology (01-08-2008)“…Abstract Objective Tumor markers with increased sensitivity and specificity for endometrial cancer are needed to help monitor response to therapy and to detect…”
Get full text
Journal Article -
8
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways
Published in Oncogene (05-01-2012)“…Ovarian cancers migrate and metastasize over the surface of the peritoneal cavity. Consequently, dysregulation of mechanisms that limit cell migration may be…”
Get full text
Journal Article -
9
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
Published in Gynecologic oncology (01-09-2007)“…Abstract Objectives. Early detection of ovarian cancer should improve overall survival. Multiple serum markers have been evaluated as possible tests to detect…”
Get full text
Journal Article -
10
Urinary levels of Bcl-2 are elevated in ovarian cancer patients
Published in Gynecologic oncology (01-01-2009)“…Abstract Objective(s) The poor prognosis associated with ovarian cancer is due to the lack of overt early symptoms and the absence of reliable diagnostic…”
Get full text
Journal Article -
11
Prevention and early detection of ovarian cancer: mission impossible?
Published in Recent results in cancer research (2007)“…Epithelial ovarian cancer is neither a common nor a rare disease. In the United States, the prevalence of ovarian cancer in postmenopausal women (1 in 2,500)…”
Get more information
Journal Article -
12
Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers
Published in Methods in enzymology (2006)“…ARHI is a maternally imprinted tumor suppressor gene that is downregulated in 60% of ovarian and breast cancers. Loss of ARHI expression is associated with…”
Get more information
Journal Article -
13
The role of the conserved N -terminal domain of STAT3 in STAT3 dephosphorylation and nuclear export
Published 01-01-2004“…Rapid redistribution of STAT subcellular localization is an essential feature of cytokine signaling. To elucidate the molecular basis of STAT3 function, which…”
Get full text
Dissertation